Comparative Study
doi: 10.1136/bmj.304.6830.841-a.
Renal protective effect of enalapril in diabetic nephropathy
- PMID: 1489422
- PMCID: PMC1881682
- DOI: 10.1136/bmj.304.6830.841-a
Item in Clipboard
Comparative Study
Renal protective effect of enalapril in diabetic nephropathy
BMJ.
.
No abstract available
Comment on
-
Renal protective effect of enalapril in diabetic nephropathy.BMJ. 1992 Feb 8;304(6823):339-43. doi: 10.1136/bmj.304.6823.339. BMJ. 1992. PMID: 1540729 Free PMC article. Clinical Trial.
Similar articles
-
Enalapril and metoprolol in diabetic nephropathy.BMJ. 1990 Jun 2;300(6737):1466. doi: 10.1136/bmj.300.6737.1466-a. BMJ. 1990. PMID: 2379011 Free PMC article. No abstract available.
-
Enalapril and metoprolol in diabetic nephropathy.BMJ. 1990 May 26;300(6736):1399. doi: 10.1136/bmj.300.6736.1399. BMJ. 1990. PMID: 2372593 Free PMC article. No abstract available.
-
Renal protective effect of enalapril in diabetic nephropathy.BMJ. 1992 Feb 8;304(6823):339-43. doi: 10.1136/bmj.304.6823.339. BMJ. 1992. PMID: 1540729 Free PMC article. Clinical Trial.
-
Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.Acta Diabetol. 2005 Apr;42 Suppl 1:S42-9. doi: 10.1007/s00592-005-0180-4. Acta Diabetol. 2005. PMID: 15868119 Review.
-
[The ACE inhibitor spirapril in chronic renal failure, hypertension and diabetic nephropathy].Ter Arkh. 2000;72(10):78-82. Ter Arkh. 2000. PMID: 11220886 Review. Russian.
Cited by
-
Specific MAPK inhibitors prevent hyperglycemia-induced renal diseases in type 1 diabetic mouse model.Mol Cell Biochem. 2016 Aug;419(1-2):1-9. doi: 10.1007/s11010-016-2722-1. Epub 2016 Jul 7. Mol Cell Biochem. 2016. PMID: 27389030
-
Efficacy of pentoxifylline for reduction of proteinuria in type II diabetic patients.Caspian J Intern Med. 2011 Fall;2(4):309-13. Caspian J Intern Med. 2011. PMID: 24551437 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical